Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
18 participants
INTERVENTIONAL
2005-09-30
2006-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Inside a Snoezelen room you will find, dimmed lights, a relaxed atmosphere and pleasant surroundings, soothing sounds, intriguing aromas, tasty puddings, candies, interesting light effects (fiber optic light spray), comfortable seating, opportunities for interaction and engagement, sense of control over environment, tactile objects (awareness box), bubble tube, solar projector wheel, water fountain, massage pillow, massage tube, tranquility and solitude. The Snoezelen room is an environment in which the primary senses (see, hear, taste, touch) are stimulated all to create an environment that is both relaxing and stimulating. The benefits of Snoezelen change per person but may include some of the following:
* Increased resident and caregiver communication
* Increased awareness and understanding of the environment
The Snoezelen idea: client-controlled, safe comfortable atmosphere and freedom from pressure.
Sensory Deprivation (loss) The average person touches 300 different surfaces every 30 minutes. The average person with a profound disability will likely touch 1-5 surfaces in the same time frame.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Subject receives Snoezelen sessions once per week.
Snoezelen Room
Session in a Snoezelen room once per week for 12 weeks
2
Subject receives Snoezelen sessions three times per week.
Snoezelen Room
Session in a Snoezelen room three times per week for 12 weeks
3
Subject receives no sessions per week.
Control
Receive no sessions in a Snoezelen Room.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Snoezelen Room
Session in a Snoezelen room once per week for 12 weeks
Snoezelen Room
Session in a Snoezelen room three times per week for 12 weeks
Control
Receive no sessions in a Snoezelen Room.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Residents having a Mini Mental State Exam with a score of 15 to 27 reflecting mild to moderate dementia;
* Male or female over 65 years of age;
* Resident who are able to leave the terrace;
* Resident who are not actively participating in Life Enrichment Programs;
* Able to provide informed written and signed consent by resident or substitute decision maker.
Exclusion Criteria
* Severe mental disorder in the opinion of the investigator (i.e. bipolar, schizophrenia);
* No recent change in medication(s) during the past four weeks prior to the project;
* Other non-Alzheimer-Type Dementia;
* Residents who suffer from Epilepsy.
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Queen's University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Roumen Milev
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roumen V. Milev, MD
Role: PRINCIPAL_INVESTIGATOR
Queen's University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rideaucrest Home
Kingston, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PSIY-205-05
Identifier Type: -
Identifier Source: org_study_id